Notice of Intent to Limit Sources - Business Data Enrichment Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contract Value
Not provided
Codes & Classification
Solicitation Number
FDA-NOI-75F40125Q00020
NAICS
541519 - Other Computer Related Services
Classification Code
DA10
Additional Details
The Department of Health and Human Services (HHS), through its Office of Mission Acquisition Solutions (OMAS), has issued a Special Notice indicating its intent to make a sole-source award for business data enrichment services in support of the Food and Drug Administration (FDA). This procurement activity is not a solicitation or request for quotation; rather, it serves as a public notification of the agency’s plan to limit sources for this requirement, specifically to Dun & Bradstreet Inc. (D&B), located at 11710 Plaza America Drive, Suite 900, Reston, VA 20190.
The primary purpose of this procurement is to secure perpetual and term licenses, database access, professional verification services, and professional IT services necessary to integrate a commercial off-the-shelf (COTS) solution into FDA systems and ensure its ongoing operation. The intended outcome is to maintain and enhance the FDA’s ability to accurately identify, verify, and track business entities as part of its regulatory responsibilities.
A key driver for this sole-source action is the FDA’s statutory reliance on the Data Universal Numbering System (DUNS), which is both created and maintained exclusively by D&B. The DUNS number serves as the FDA’s Unique Facility Identifier (UFI) under the FDA Safety and Innovation Act of 2012 (FDASIA), and is deeply embedded in the agency’s regulatory framework. This identifier is critical for drug establishment registration, user fee assessments, ethics determinations, food and medical device registration, and import screening, impacting approximately 1.9 million firms worldwide. Transitioning to an alternative identifier system would necessitate extensive re-engineering of 18 FDA applications and could disrupt ongoing regulatory processes, posing significant mission risk.
D&B’s proprietary global database, which encompasses over 500 million company records across more than 200 countries and is updated 1.5 million times daily, is central to the FDA’s requirements. The company’s entity matching capabilities, which link corporate family relationships and track business entities using data from over 20,000 sources, are unique and require direct access to D&B’s systems.
The scope of services to be provided includes:
1. Manual lookup services with read access to D&B’s systems.
2. Physical investigations (PIs) involving on-site visits to verify business entities.
3. Global verification services leveraging human intelligence capabilities.
These services are essential for the FDA, which lacks the personnel and resources to conduct such extensive international verifications independently. No other vendor is capable of providing these services at the required scale and with the necessary proprietary data access.
The procurement is classified under NAICS Code 541519 (Other Computer Related Services), with Product Service Code DA10. There are no set-aside requirements associated with this action. The place of performance is Maryland, United States.
Interested parties may submit information regarding their capabilities; however, the government’s decision not to compete this requirement is at its sole discretion. All responses must be directed to the Contract Specialist, Renee Jones-Chuang, at [email protected].
This notice is inactive and was posted on March 16, 2026, with a response deadline of February 27, 2026. Further details can be found at the official SAM.gov opportunity listing: https://sam.gov/opp/73ec66875597424e84fe6e83ec526d70/view.
Contractors considering this opportunity should note the highly specialized and proprietary nature of the required services, the statutory and operational reliance on D&B’s systems, and the absence of set-aside or competitive solicitation processes.